Percutaneous Femoropopliteal Recanalization Using a Completely Transpedal/Transtibial Approach

Timothy W I Clark1, Micah M Watts2, Tak W Kwan3

  • 1Section of Interventional Radiology, Department of Radiology, Penn Presbyterian Medical Center, University of Pennsylvania Medical Center, 39th and Market Streets, Philadelphia, PA, 19104, USA. timothy.clark@uphs.upenn.edu.

Insights

This study shows that a transpedal/transtibial approach is a viable option for femoropopliteal revascularization. This technique successfully treated severe leg artery disease without complications, offering an alternative when traditional access is limited.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Endovascular Interventions

Background:

  • Femoropopliteal revascularization is crucial for treating peripheral artery disease.
  • Traditional access via the common femoral artery can be challenging in some patients.
  • Minimally invasive techniques are increasingly explored to improve patient outcomes.

Observation:

  • A novel approach utilizing exclusively pedal or tibial arteries for access was employed.
  • Three patients with severe (Rutherford 3-4) femoropopliteal disease (TASC C/D lesions) underwent this technique.
  • The approach facilitated successful revascularization in complex arterial occlusions and previously stented segments.

Findings:

  • Successful revascularization was achieved in all three patients.
  • Treatments included reentry and stenting for chronic superficial femoral artery occlusion, endograft revision of a popliteal artery stent, and stenting of a chronic SFA occlusion.
  • Complete symptom resolution was observed in all patients.
  • No complications related to the pedal/tibial puncture sites occurred.

Implications:

  • The transpedal/transtibial approach offers a promising alternative access strategy for femoropopliteal revascularization.
  • This technique expands treatment options for patients with limited or unsuitable femoral access.
  • It may represent an important advancement in endovascular treatment for critical limb ischemia.
Abstract